Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 5, 1997, Pages 639-651

  Bauernfeind, A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 CYCLOPROPYL 7 (2,8 DIAZABICYCLO[4,3,0]NON 8 YL) 6 FLUORO 8 METHOXY 1,4 DIHYDRO 4 OXO 3 QUINOLINE; CIPROFLOXACIN; CLINAFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; CAMPYLOBACTER JEJUNI; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENTEROBACTERIACEAE; GRAM POSITIVE COCCI; HELICOBACTER PYLORI; NONHUMAN; PSEUDOMONAS;

ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BACTERIA; CIPROFLOXACIN; ENTEROBACTERIACEAE; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; NAPHTHYRIDINES; OFLOXACIN; PIPERAZINES; QUINOLINES; QUINOLONES; STAPHYLOCOCCUS AUREUS;

EID: 0030831857     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bauernfeind, A. (1993). Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, Cl-960 and Cl-990. Journal of Antimicrobial Chemotherapy 31, 505-22.
2. Aguiar, J. M., Chacon, J., Canton, R. & Baquero, F. (1992). The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections. Journal of Antimicrobial Chemotherapy 29, 349-50.
3. Alarcón, T., Pita, J., López-Brea, M. & Piddock, L. J. V. (1993). High-level quinolone resistance amongst clinical isolates of Escherichia coli and Klebsiella pneumoniae from Spain. Journal of Antimicrobial Chemotherapy 32, 605-9.
4. Bauernfeind, A., Abele-Horn, M., Emmerling, P. & Jungwirth, R. (1994). Multiclonal emergence of ciprofloxacin-resistant clinical isolates of Escherichia coli and Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy 34, 1074-6.
5. Kern, W. V., Andriof, E., Oethinger, M., Kern, P., Hacker, J. & Marre, R. (1994). Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrobial Agents and Chemotherapy 38, 681-7.
6. Dalhoff, A., Petersen, U. & Endermann, R. (1996). In vitro activity of Bay 12-8039, a new 8-methoxyquinolone. Chemotherapy 42, 410-25.
7. Petersen, U., Bremm, K.-D., Dalhoff, A., Endermann, R., Heilmann, W., Krebs, A. et al. (1996). Synthesis and in vitro activity of Bay 12-8039, a new 8-methoxy-quinolone. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract F1, p. 100. American Society for Microbiology, Washington, DC.
8. Hirai, K., Hosaka, M., Niwata, Y., Yasue, T., Fukada, H., Ishizaki, T. et al. (1990). Antibacterial activity of AM-1155, a new quinolone. In Program and Abstracts of the Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, GA, 1990. Abstract 385, p. 151. American Society for Microbiology, Washington, DC.
9. Gootz, T. D., Brighty, K., Anderson, M., Schmieder, B., Haskells, S., Sutcliffe, J. et al. (1992). In vitro activity and synthesis of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone. In Program and Abstracts of the Thirty-Second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA, 1992. Abstract 751, p. 235. American Society for Microbiology, Washington, DC.
10. Norrby, S. R. & Jonsson, M. (1988). Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative. Antimicrobial Agents and Chemotherapy 32, 1278-81.
11. Une, T., Fujimoto, T., Sato, K. & Osada, Y. (1988). In vitro activity of DR-3355, an optically active ofloxacin. Antimicrobial Agents and Chemotherapy 32, 1336-40.
12. National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Third Edition; Approved Standard M7-A3. NCCLS, Villanova, PA.
13. Domagala, J. M. (1994). Structure-activity and structure-side-effect relationships for the quinolone antibacterials. Journal of Antimicrobial Chemotherapy 33, 685-706.
14. Felmingham, D., Grüneberg, R. N. & The Alexander Project Group. (1996). A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 1-57.
15. Campos, J., Román, F., Georgiou, M., García, C., Gomez-Lus, R., Cantón, R. et al. (1996). Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. Journal of Infectious Diseases 174, 1345-7.
16. Goldstein, F. W., Acar, J. F. & The Alexander Project Collaborative Group. (1996). Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992-93 Western Europe and USA collaborative surveillance study. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 71-84.
17. Schito, G. C., Debbia, E. A., Pesce, A. & The Alexander Project Collaborative Group. (1996). Susceptibility of respiratory strains of Staphylococcus aureus to fifteen antibiotics: results of a collaborative surveillance study (1992-1993). Journal of Antimicrobial Chemotherapy 38, Suppl. A, 97-106.